GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alternate Health AHGIF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Alternate Health

Its shares trade under the ticker AHGIF. It has been listed since 26 January 2017. In the fiscal year to 31 December 2018, it reported revenue of C$577,200 and a net loss of C$24.0m. At that date it held total assets of C$9.6m and shareholders' equity of C$1.1m.

Alternate Health Corp. is a medical cannabis company engaged in the manufacturing and distribution of cannabis products. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-01-26. The firm manufactures, packages, and distributes pharmaceutical grade products across the United States. The company is a diverse healthcare provider that uses technology and data analytics for patient care and research in the CBD industry. Through its subsidiaries, it offers services ranging from medical practice and management software, clinical research and continuing education programs. Its products line includes topical creams and tinctures for the treatment of pain, scares, and fungus. The company also manufactures and distributes Hempnesic, which is a hemp-based pain management cream. The firm's software systems provide the platform for its diverse operations, including CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection systems, education modules and electronic medical records (EMR) platforms. Its subsidiaries include Alternate Health, Inc. and Alternate Health USA Inc.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
26 Jan 2017

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Manufactures pharmaceutical grade cannabis products across the United States.
  • Offers diverse healthcare services including medical practice software and clinical research.
  • Distributes Hempnesic, a hemp-based pain management cream for pain treatment.

Weaknesses

  • Headquartered in Toronto, Ontario, with operations primarily in the United States.
  • IPO listed on 26 January 2017, which may limit recent growth opportunities.
  • Uses technology and data analytics for patient care but lacks specific product innovation details.

Opportunities

  • Expands into the growing CBD industry with topical creams and tinctures.
  • Leverages blockchain tax collection systems for efficient operations.
  • Grows through subsidiaries like Alternate Health USA Inc. in the U.S. market.

Threats

  • Regulatory challenges in the U.S. cannabis market may affect distribution.
  • Competition from other CBD product manufacturers in the health care sector.
  • Limited international expansion beyond the United States and Canada.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.